BIOMAT Database Logo BIOMAT Database Logo

Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? 2013

Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019797 3-Iodobenzylguanidine A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase. (3-Iodo-(131I)benzyl)guanidine,Iobenguane,MIBG,3-Iodobenzylguanidine, 123I Labeled,3-Iodobenzylguanidine, 125I Labeled,Iobenguane (131I),m-Iodobenzylguanidine,meta-Iodobenzylguanidine,123I Labeled 3-Iodobenzylguanidine,125I Labeled 3-Iodobenzylguanidine,3 Iodobenzylguanidine,3 Iodobenzylguanidine, 123I Labeled,3 Iodobenzylguanidine, 125I Labeled,m Iodobenzylguanidine,meta Iodobenzylguanidine

Related Publications

Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease.
December 2019, Journal of the neurological sciences,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.
October 2023, Brain sciences,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase?
January 2019, Neuro-degenerative diseases,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
[Early differential diagnosis of dysautonomia in Parkinson's disease by means of cardiac scintigraphy with 123I-MIBG].
January 2009, Revista de neurologia,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease.
September 2015, Journal of neurology, neurosurgery, and psychiatry,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Correlation with sympathetic skin response, 123I-MIBG scintigraphy, and 123I-FP-CIT SPECT in Parkinson's disease.
February 2024, Neurophysiologie clinique = Clinical neurophysiology,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
[The efficacy of early 123I-MIBG scintigraphy for pheochromocytoma diagnosis].
July 1995, Kaku igaku. The Japanese journal of nuclear medicine,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease.
January 2019, Frontiers in neurology,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Association of plasma α-synuclein with cardiac 123I-MIBG scintigraphy in early Parkinson's disease.
January 2022, Neuroscience letters,
Agostino Chiaravalloti, and Alessandro Stefani, and Mariangela Pierantozzi, and Paolo Stanzione, and Orazio Schillaci
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
February 2005, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!